Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pronova BioPharma, a provider of marine-originated omega-3 derived pharmaceutical products, has appointed Per-Oluf Olsen as its new CEO to succeed Tomas Settevik, who has informed the board that he wishes to stand down from his position as CEO.
Subscribe to our email newsletter
Mr Olsen will assume the role of CEO, effective November 17, 2008. Mr Olsen joins Pronova BioPharma after 27 years with Pfizer where he gained extensive international experience in sales, marketing and management.
Most recently, Mr Olsen was regional executive director for central and eastern European region, inclusive regional office in Brussels. He was previously country manager for Pfizer in Italy, Norway and Denmark and has held a number of senior sales and marketing positions for the company in Norway and the US.
Gert Munthe, chairman of Pronova BioPharma, said: “I am pleased to announce Per-Oluf Olsen as the new CEO. He has an attractive background from the international pharmaceutical industry and a broad range of sales, marketing, and management experience, which will be a valuable contribution for Pronova BioPharma’s future growth and success. The board would like to thank Mr Settevik for his dedication and significant contribution to Pronova BioPharma’s success to date.”